Bernstein Downgrades Human Genome (HGSI) to Market Perform
Tweet Send to a FriendGet Alerts HGSI Hot Sheet
Price: $14.24 --0%
Rating Summary:
5 Buy, 18 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 24 | Down: 17 | New: 24
Rating Summary:
5 Buy, 18 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 24 | Down: 17 | New: 24
Trade HGSI Now!
Bernstein downgrades Human Genome (Nasdaq: HGSI) downgraded from Outperform to Market Perform.
Shares of HGSI last traded at $29.85 in pre-open trading this morning, slightly below Friday's close of $29.99. The 52-week range is $17.30-$34.49.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Shares of HGSI last traded at $29.85 in pre-open trading this morning, slightly below Friday's close of $29.99. The 52-week range is $17.30-$34.49.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: UBS Downgrades SunTrust Banks (STI) to Neutral
- Barclays Downgrades Javelin Mortgage (JMI) to Underweight
- Jefferies Downgrades Chevron (CVX) to Hold
Create E-mail Alert Related Categories
Downgrades
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
